Separation and identification of phase I and phase II [14C]antipyrine metabolites in rat and dog urine
- 7 April 1995
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 666 (1), 139-147
- https://doi.org/10.1016/0378-4347(94)00552-g
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Metabolism of metronidazole and antipyrine in isolated rat hepatocytesBiochemical Pharmacology, 1989
- Antipyrine as a model drug to study hepatic drug-metabolizing capacityJournal of Hepatology, 1988
- Inhibition of antipyrine metabolite formation in ratsin vivoXenobiotica, 1984
- Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in ratsXenobiotica, 1983
- Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivoXenobiotica, 1983
- High-performance liquid chromatography of curcumin and related compoundsJournal of Chromatography A, 1983
- Differential effects of enzyme induction on antipyrine metabolite formation.British Journal of Clinical Pharmacology, 1982
- Quantitation and urinary pattern of 4,4′-dihydroxyantipyrine, 4-hydroxy-antipyrine and 3-hydroxymethyl-antipyrine, as main metabolites of antipyrine in man and ratJournal of Pharmacy and Pharmacology, 1982
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in ManPharmacology, 1979